Immunomedics submits LeukoScan to FDA

January 8, 1997

Immunomedics of Morris Plains, NJ, has submitted a biologies licenseapplication to the Food and Drug Administration for approval ofLeukoScan, a technetium-99m-labeled monoclonal antibody-basedagent for imaging bone infection. LeukoScan received a

Immunomedics of Morris Plains, NJ, has submitted a biologies license

application to the Food and Drug Administration for approval of

LeukoScan, a technetium-99m-labeled monoclonal antibody-based

agent for imaging bone infection. LeukoScan received a positive

recommendation from Europe's Committee for Proprietary Medicinal

Products in October (SCAN 10/23/96).